Lifitegrast
Back to searchMolecule Structure
Scientific Name
Lifitegrast
Description of the Drug
Lifitegrast is a medication used to treat dry eye disease.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB11611
http://www.drugbank.ca/drugs/DB11611
Brand Name(s)
Xiidra
Company Owner(s)
Novartis Pharmaceuticals Corp
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Integrin alpha-L/beta-2 (LFA-1) | PROTEIN COMPLEX | ANTAGONIST | CHEMBL2364172 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL2632068 | |
| DrugBank | DB11611 | |
| PubChem: Thomson Pharma | 17424515 | |
| PubChem | 11965427 | |
| BindingDB | 50386331 | |
| EPA CompTox Dashboard | DTXSID60145345 | |
| DrugCentral | 5174 | |
| ChemicalBook | CB92738258 | |
| Guide to Pharmacology | 7533 | |
| rxnorm | LIFITEGRAST | XIIDRA |
| ChEBI | 133023 | |
| ZINC | ZINC000084668739 |
